For Healthcare Professionals

Evaluation of Droplet Digital PCR Rapid Detection Method and Precise Diagnosis and Treatment for Suspected Sepsis

clipboard-pencil

About the study

Sepsis is a significant public health concern worldwide, with high morbidity and mortality. With regard to a targeted antimicrobial treatment strategy, the earliest possible pathogen detection is of crucial importance. Until now, culture-based detection methods represent the diagnostic gold standard, although they are characterized by numerous limitations. Culture-independent molecular diagnostic procedures may represent a promising alternative. In particular, droplet digital PCR (ddPCR) is a novel one-step PCR assay that achieves higher accuracy and sensitivity in detecting causing pathogens in patients with bloodstream infections.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

Inclusion Criteria:

1.18 years or older

2.Meet 2 of 4 sepsis criteria

  1. Temperature > 38C or < 36C
  2. Heart rate > 90 bpm
  3. Respiratory rate >20 or PaCO2 <32mmHg

WBC >12000/µL or < 4000/µL or > 10% bands

3.Hospitalized patients who have a diagnostic blood culture ordered as standard of care for suspected sepsis

4.Informed Consent by patient or legal representative.

EXCLUSION CRITERIA

Exclusion Criteria:

  1. Refusal to participate in the study or Failure to comply with treatment or follow-up time
  2. Known breastfeeding or pregnancy
  3. The researcher believes that there are any conditions (social or medical) that allow subjects to participate is unsafe. For example, severe anemia or high risk of bleeding,etc., which are not suitable for taking peripheral blood for testing
  4. Participating in other clinical studies
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.

Study’s details


Contition

Sepsis,Septic Shock

Age (in years)

18+

Phase

Not Applicable

Participants needed

2000

Est. Completion Date

Jun 1, 2023

Treatment type

Interventional


Sponsor

Huashan Hospital

ClinicalTrials.gov identifier

NCT05190861

Study number

PROGRESS

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.